FDA Adverse Event Injury Summary report: N

ANCURE ENDOGRAFT (FORMERLY EVT ENDOGRAFT)

MDR report key: 5667374 · Received May 19, 2016

Report

Report Number
2954310-2016-81825
Event Type
Injury
Date Received
May 19, 2016
Date of Event
December 1, 2015
Report Date
April 26, 2016
Manufacturer
GUIDANT ENDOVASCULAR SOLUTIONS
Product Code
MIH
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION REGARDING THE ANCURE PRODUCTS FROM THE ARTICLE AUTHOR WERE UNSUCCESSFUL. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED. REFERENCE: LAL, B.K., ZHOU, W., LI, ZIYI, KYRIAKIDES, T., MATSUMURA, J., LEDERLE, F.A., AND FREISCHLAG, J. PREDICTORS AND OUTCOMES OF ENDOLEAKS IN THE VETERANS AFFAIRS OPEN VERSUS ENDOVASCULAR REPAIR (OVER) TRIAL OF ABDOMINAL AORTIC ANEURYSMS. JOURNAL OF VASCULAR SURGERY. 2015; 62 (6): 1394-1404.

Description of Event or Problem · 1

BOSTON SCIENTIFIC (FORMERLY GUIDANT) RECEIVED INFORMATION FROM THIS JOURNAL ARTICLE OF A STUDY CONDUCTED TO COMPARE OPEN VS ENDOVASCULAR REPAIR (EVAR) IN STANDARD-RISK PATIENTS WITH INFRA-RENAL AORTIC ANEURYSMS. THE ARTICLE REPORTED THAT ENDOGRAFTS WERE USED FROM SEVERAL DIFFERENT MANUFACTURERS, INCLUDING BOSTON SCIENTIFIC. THE ARTICLE REPORTED THAT ONE ANCURE ENDOGRAFT RESULTED IN A TYPE I ENDOLEAK. NO SPECIFIC MODEL AND SERIAL INFORMATION WAS LISTED IN THE ARTICLE. THE ONLY PATIENT INFORMATION PROVIDED WAS THAT ALL PATIENTS WHO EXPERIENCED ENDOLEAKS WERE MALE. IT IS UNKNOWN IF ANY INTERVENTIONS WERE PERFORMED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
321965 ANCURE ENDOGRAFT (FORMERLY EVT ENDOGRAFT) GRAFT MIH GUIDANT ENDOVASCULAR SOLUTIONS

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R